Quarterly Result5 Feb 2026, 06:03 pm
Windlas Biotech Ltd Announces Q3 and Nine Months Results for 2025, Reports Profit of 797.58 Million INR
AI Summary
Windlas Biotech Ltd, a leading pharmaceutical company, announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported a profit before tax of 797.58 million INR. The revenue from operations stood at 2,331.02 million INR for the quarter. The board also approved the closure of its non-operative wholly owned subsidiary, Windlas Inc. USA.
Key Highlights
- Windlas Biotech Ltd announced its Q3 and nine months results for 2025.
- The company reported a profit before tax of 797.58 million INR.
- Revenue from operations stood at 2,331.02 million INR for the quarter.
- The board approved the closure of its non-operative wholly owned subsidiary, Windlas Inc. USA.
- The results were reviewed by the audit committee and approved by the board of directors.